FDA changed its accelerated approval of blinatumomab (Blincyto) for some patients with acute lymphoblastic leukemia to a full approval and expanded the approved indications for its use.
from # & - All via ola Kala on Inoreader http://ift.tt/2eLwAGN
FDA changed its accelerated approval of blinatumomab (Blincyto) for some patients with acute lymphoblastic leukemia to a full approval and expanded the approved indications for its use.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου